CLINICAL_TRIALS
trial_result
· 2012-04-23
Clinical Trial Update: Randomized Gefitinib Trial [Phase 3]
Summary
A Phase 3 randomized trial of gefitinib for non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fondazione Humanitas per la Ricerca | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED